ArticleTranslational oncology2024

Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma.

Heng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.